Skip to content
10-K

Annual Report

VERVE THERAPEUTICS, INC.

0000950170-25-028376

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 20, 2025 88.8M sh
Shares Diluted FY 2024 · Dec 31, 2024 84.72M sh
Shares Diluted FY 2024 · Dec 31, 2023 64.18M sh
Shares Diluted FY 2024 · Dec 31, 2022 54.02M sh
Capex FY 2024 · Dec 31, 2024 $3.74M
Capex FY 2024 · Dec 31, 2023 $9.28M
Capex FY 2024 · Dec 31, 2022 $13.23M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$157.69M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$149.55M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$122.33M
Cash And Equivalents FY 2024 · Dec 31, 2024 $172.56M
Cash And Equivalents FY 2024 · Dec 31, 2023 $206.18M
Stockholders Equity FY 2024 · Dec 31, 2024 $493.4M
Stockholders Equity FY 2024 · Dec 31, 2023 $599.5M
Stockholders Equity FY 2024 · Dec 31, 2022 $550.93M
Stockholders Equity FY 2024 · Dec 31, 2021 $357.35M
Current Liabilities FY 2024 · Dec 31, 2024 $42.91M
Current Liabilities FY 2024 · Dec 31, 2023 $37.01M
Total Liabilities FY 2024 · Dec 31, 2024 $153.99M
Total Liabilities FY 2024 · Dec 31, 2023 $153.19M
Current Assets FY 2024 · Dec 31, 2024 $542.75M
Current Assets FY 2024 · Dec 31, 2023 $637.95M
Total Assets FY 2024 · Dec 31, 2024 $647.39M
Total Assets FY 2024 · Dec 31, 2023 $752.69M
Eps Diluted FY 2024 · Dec 31, 2024 −$2.35
Eps Diluted FY 2024 · Dec 31, 2023 −$3.12
Eps Diluted FY 2024 · Dec 31, 2022 −$2.91
Eps Basic FY 2024 · Dec 31, 2024 −$2.35
Eps Basic FY 2024 · Dec 31, 2023 −$3.12
Eps Basic FY 2024 · Dec 31, 2022 −$2.91
Sga Expense FY 2024 · Dec 31, 2024 $56.65M
Sga Expense FY 2024 · Dec 31, 2023 $49.94M
Sga Expense FY 2024 · Dec 31, 2022 $37.53M
Rd Expense FY 2024 · Dec 31, 2024 $204.35M
Rd Expense FY 2024 · Dec 31, 2023 $184.95M
Rd Expense FY 2024 · Dec 31, 2022 $130.1M
Net Income FY 2024 · Dec 31, 2024 −$198.71M
Net Income FY 2024 · Dec 31, 2023 −$200.07M
Net Income FY 2024 · Dec 31, 2022 −$157.39M
Operating Income FY 2024 · Dec 31, 2024 −$228.66M
Operating Income FY 2024 · Dec 31, 2023 −$223.12M
Operating Income FY 2024 · Dec 31, 2022 −$165.69M